Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Lack of Association between IL-6 Polymorphisms and Haplotypes with Gastric Cancer

Full text
Author(s):
dos Santos, Monica Pezenatto [1] ; Sallas, Mayara Luciana [1] ; Zapparoli, Diana [1] ; Orcini, Wilson Aparecido [1] ; Chen, Elizabeth [2] ; Cardoso Smith, Marilia de Arruda [2] ; Marques Payao, Spencer L. [3] ; Rasmussen, Lucas Trevizani [3, 1]
Total Authors: 8
Affiliation:
[1] USC, Sao Paulo - Brazil
[2] Univ Fed Sao Paulo UNIFESP, Sao Paulo - Brazil
[3] Fac Med Marilia FAMEMA, Hemoctr, Sao Paulo - Brazil
Total Affiliations: 3
Document type: Journal article
Source: Journal of Cellular Biochemistry; v. 120, n. 6, p. 9448-9454, JUN 2019.
Web of Science Citations: 2
Abstract

The process of combating neoplasms and mononuclear cells, and during H. pylori infection, several pro-inflammatory and anti-inflammatory cytokines are synthesized. In view of the involvement of the IL-6 law and the presence of H. pylori in the development of gastric diseases, the present study aimed to characterize the promoter-region polymorphism -597 (G/A) (rs1800797), -572 (C/G) (rs1800796), and -174 (G/C) (rs1800795) by PCR-RFLP in 375 gastric biopsy specimens from patients with peptic symptoms. A total of 375 samples were analyzed: 87 patients (without lesion without gastric tissue); 236 patients with gastritis and 52 patients with gastric cancer analyzed the PCR-RFLP techniques. All the results were normalized in relation to the presence of H. pylori. The frequencies of the three polymorphisms were compared in the Control vs Gastritis groups and a statistically significant test observed: -174 (G/C) (OR: 1.27; 95% CI: 0.84-1.93; P=0.26), 572 (C/G) (OR: 1.42; 95% CI: 0.78-2.59; P=0.25), and 597 (G/A) (OR: 0.98; 95% CI, 0.64-1.52; P=0.94). Similar results were obtained when the gastric cancer group was compared to the control group: -174 (G/C) (OR: 1.27; 95% CI: 0.66-2.47; P=0.47), -572 (C/G) (OR: 1.07; 95% CI: 0.43-2.68; P=0.88), and -597 (G/A) (OR: 1.01; 95% CI, 0.5-0.9; P=0.99). The haplotypes were and were not observed statistically significant differences. In conclusion, we found no correlations between any of the three polymorphisms in the IL-6 gene analyzed in this study and a higher risk of gastritis or gastric cancer. (AU)

FAPESP's process: 18/08481-1 - Gene and protein interaction among components of the inflammatory, apoptosis and microRNAs pathways in gastric disease and gastric cancer
Grantee:Lucas Trevizani Rasmussen
Support type: Regular Research Grants
FAPESP's process: 15/11371-5 - Analysis of expression of Micro RNAs and genes associated with apoptosis and chronic inflammation in gastric diseases: a possible relation with Helicobacter pylori
Grantee:Lucas Trevizani Rasmussen
Support type: Regular Research Grants